USA Financial Formulas’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-480
Closed -$87K 453
2021
Q4
$87K Buy
+480
New +$83.3K 0.07% 135
2021
Q2
Sell
-1,309
Closed -$170K 427
2021
Q1
$170K Buy
+1,309
New +$168K 0.14% 136
2018
Q1
Sell
-7,502
Closed -$364K 383
2017
Q4
$364K Buy
+7,502
New +$379K 0.09% 202

Other funds holding OMCL

USA Financial Formulas's OMCL Position: Q1 2022 in Review

USA Financial Formulas sold out of Omnicell (OMCL) in Q1 2022, closing a stake of 480 shares — an estimated $87K sold.

USA Financial Formulas first reported a position in OMCL in Q4 2017 and held it in 3 quarters. The position peaked at $364K in Q4 2017. 397 funds tracked by Wall St. Rank hold OMCL as of Q1 2022.

  • USA Financial Formulas reported no remaining Omnicell position as of Q1 2022 after selling out during the quarter.
  • USA Financial Formulas sold 480 Omnicell shares in Q1 2022, an estimated $87K.
  • USA Financial Formulas first reported a position in Omnicell in Q4 2017 and held it in 3 quarters.
  • USA Financial Formulas's Omnicell position peaked at $364K in Q4 2017.
  • 397 funds tracked by Wall St. Rank held Omnicell as of Q1 2022.

Based on USA Financial Formulas's 13F filing for Q1 2022, filed 16 Aug 2022.